a Department of Pharmaceutical Biotechnology , Faculty of Pharmacy, Marmara University , Haydarpaşa, Istanbul , Turkey.
b Department of Bioengineering , Faculty of Engineering, Marmara University , Göztepe, Istanbul , Turkey , and.
Pharm Dev Technol. 2017 Aug;22(5):627-634. doi: 10.3109/10837450.2015.1116564. Epub 2015 Nov 25.
Encapsulation of vancomycin (VANCO) into biodegradable levan microparticles was achieved using a simple preparation technique. Microparticles were prepared by using levan polysaccharide produced by a halophilic bacterium Halomonas smyrnensis AAD6. To optimize efficiency of encapsulation process by precipitation method, three parameters were studied: drug and polymer concentrations and preparation rotating speed. The particles were characterized in vitro. The size of levan microparticles was changed between 0.404 μm and 1.276 μm. The surface charge was detected between +4.1 mV and +6.5 mV. The highest drug encapsulation capacity of the system was 74.7% and was depending on the polymer concentration. In dissolution studies, initial burst effect around 10-20% from all the formulations was observed and then the release was slowed down and continued at a constant level. In vitro antibiotic release from the microparticles was controlled with the drug carrier system and release fit to Higuchi kinetic model. All the released samples collected at different time intervals during dissolution studies have exhibited intrinsic bactericidal activity against Bacillus subtilis ATCC 6633. WST-1 cell proliferation and viability studies showed that VANCO-loaded levan microparticles at concentrations between 100 μg/mL and 1000 μg/mL were nontoxic to L929 cells. As conclusion, levan microparticulate system could be a potential carrier of antibiotic drugs such as VANCO.
通过简单的制备技术,将万古霉素(VANCO)包封到可生物降解的黎芦醇微颗粒中。微颗粒是通过嗜盐细菌 Halomonas smyrnensis AAD6 产生的黎芦醇多糖制备的。为了通过沉淀法优化包封效率,研究了三个参数:药物和聚合物浓度以及制备旋转速度。体外对颗粒进行了表征。黎芦醇微颗粒的大小在 0.404μm 和 1.276μm 之间变化。表面电荷检测值在+4.1mV 和+6.5mV 之间。该系统的最高药物包封率为 74.7%,取决于聚合物浓度。在溶解研究中,所有制剂都观察到初始突释效应约为 10-20%,然后释放速度减慢并以恒定水平持续释放。微颗粒中抗生素的体外释放受到药物载体系统的控制,释放符合 Higuchi 动力学模型。在溶解研究过程中不同时间间隔收集的所有释放样品均对枯草芽孢杆菌 ATCC 6633 表现出固有杀菌活性。WST-1 细胞增殖和活力研究表明,浓度在 100μg/mL 和 1000μg/mL 之间的载有 VANCO 的黎芦醇微颗粒对 L929 细胞无毒。因此,黎芦醇微颗粒系统可以成为抗生素药物(如 VANCO)的潜在载体。